Product NDC: | 0904-6254 |
Proprietary Name: | Benzonatate |
Non Proprietary Name: | Benzonatate |
Active Ingredient(s): | 200 mg/1 & nbsp; Benzonatate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, LIQUID FILLED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0904-6254 |
Labeler Name: | Major Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040682 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100604 |
Package NDC: | 0904-6254-60 |
Package Description: | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0904-6254-60) |
NDC Code | 0904-6254-60 |
Proprietary Name | Benzonatate |
Package Description | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0904-6254-60) |
Product NDC | 0904-6254 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Benzonatate |
Dosage Form Name | CAPSULE, LIQUID FILLED |
Route Name | ORAL |
Start Marketing Date | 20100604 |
Marketing Category Name | ANDA |
Labeler Name | Major Pharmaceuticals |
Substance Name | BENZONATATE |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC] |